How is the International Prognostic Index (IPI) used in NHL/B-cell lymphoma?

Updated: Feb 23, 2021
  • Author: Mohammad Muhsin Chisti, MD, FACP; Chief Editor: Emmanuel C Besa, MD  more...
  • Print
Answer

To identify subgroups of patients most likely to relapse, the International Prognostic Index (IPI) was compiled for 2031 patients with aggressive NHL. [9] The IPI has been validated by several cancer centers and has been incorporated into new trials designed by various cooperative groups. (See Prognosis.)


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!